ERIC TORNGA: Open Payments
NPI 1952908139 · ALLENDALE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 64 payments from 16 companies in 2025. Trend: 2023 $2,102 · 2024 $1,993 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 24 | $345 |
| PFIZER INC. | 11 | $198 |
| ABBVIE INC. | 12 | $154 |
| Lilly USA, LLC | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Sumitomo Pharma America, Inc. | 1 | $28 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $23 |
| Verona Pharma, Inc. | 1 | $22 |
Products named: Wegovy, NURTEC ODT, Ozempic, VRAYLAR, QULIPTA, MOUNJARO, ELIQUIS, JARDIANCE.
Industry payments across MI — which companies pay providers there.
